In a previous study, 15-nm silica nanoparticles (NPs) caused small increases in DNA damage in liver as measured in the in vivo comet and micronucleus assays after intravenous administration to rats at their maximum tolerated dose, a worst-case exposure scenario. Histopathological examination supported a particle-induced, tissue damage-mediated inflammatory response. This study used a targeted approach to provide insight into the mode of action (MoA) by examining transcriptional regulation of genes in liver in a time and dose-dependent manner at 1, 2, 4, 8 and 24 h after intravenous administration of 15-nm silica NPs. DNA damage was assessed using the standard comet assay and hOGG1 glycosylase-modified comet assay that also measures oxidative DNA damage. Potassium bromate, an IARC Class 2B carcinogen that specifically operates via an oxidative stress MoA, was used as a positive control for the hOGG1 comet assay and gave a strong signal in its main target organ, the kidney, while showing less activity in liver. Treatment of rats with silica NPs at 50 mg/kg body weight (bw) caused small, statistically insignificant increases in DNA damage in liver measured by the standard comet assay, while a statistically significant increase was observed at 4 h with the hOGG1 comet assay, consistent with a MoA involving reactive oxygen species. Histopathology showed liver damage and neutrophil involvement while genomic analysis and response pattern of key genes involved in inflammation and oxidative stress supported a tissue damage-mediated inflammatory response involving the complement system for removing/phagocytising damaged cells. No changes were observed for histopathology or gene array for the low-dose (5 mg/kg bw) silica NPs. The results of this study confirm our hypothesis that the weak DNA damage observed by silica NPs occurs secondary to inflammation/immune response, indicating that a threshold can be applied in the risk assessment of these materials.
Introduction
Nanomaterials induce toxic effects by a number of different mechanisms including generation of reactive oxygen species (ROS), oxidative stress, inflammasome activation and cytokine and chemokine production (1) (2) (3) . In a previous study (4) , we have examined the potential of silica nanoparticles (NPs) to cause genotoxic effects in vitro and in vivo. Silica NPs of 15-and 55-nm nominal sizes resulted in small increases in DNA damage as measured in the in vivo comet and micronucleus assays if administered intravenously at their maximum tolerated dose (MTD), a worst-case exposure scenario. Relevant oxidative and inflammatory endpoints were examined and supported a particle-induced, tissue damage-mediated inflammatory response. We concluded that the observed profile is supportive of a secondary genotoxicity mechanism driven by inflammation (4) .
This previous study used a triple-dosing protocol as is now recommended by the OECD guidelines for use in studies combining the comet (OECD 489, 2014) and micronucleus (OECD 474, 2014) endpoints into one assay, thereby enabling a reduction in animal use (5, 6) . Data from the three dose comet/micronucleus combination study, however, do not provide ideal conditions for delineating the mode of action (MoA). The present study used a more targeted approach to provide insight into MoA by examining transcriptional regulation of genes after a single application in a time and dose-dependent manner. The sequence of events and relationship between DNA damage and inflammation was examined by measuring gene expression and DNA damage at multiple time points up to 24 h after a single intravenous (i.v.) injection, reflecting a 'worst-case' exposure scenario. The size and dose of the silica NPs [15-nm Levasil® 200, 50 mg/kg body weight (bw)] were selected to replicate the conditions that elicited the most pronounced genotoxicity effects in our previous study (4) . A low-dose group (5 mg/ kg bw) was also included and served as a control to determine whether any changes in the transcriptional expression profile could be observed at a dose for which noticeable toxic effects to the animals treated were not expected.
The comet assay was chosen for monitoring DNA damage due to its high sensitivity towards capturing DNA damage, including that triggered by ROS (7) . In addition, because the assay readout (DNA strand breaks and alkali-labile sites) does not require prior cell division, it is well suited to capture potential damage at early time points, such as those chosen for this study. The sensitivity of the comet assay for oxidative lesions, the type of damage expected based on the results of our previous study, can be improved even further by using human 8-oxo-guanine DNA glycosylase (hOGG1) or formamidopyrimidine DNA (FPG) glycosylase for recognition of oxidative DNA adducts (7, 8) . We have therefore included OGG1 treatments into this study, alongside with the standard comet assay protocol. In order to ensure proper functioning of the hOGG1 protocol, potassium bromate (KBrO 3 ), an IARC Class 2B carcinogen known to operate via an oxidative stress-specific MoA (IARC, 1999), was added as an additional positive control. Hence, we incorporated multiple, non-standard readouts into this study in an effort to delineate the MoA behind the weak, but reproducible genotoxic effects observed previously with silica NPs (4). Confirmation of a secondary (indirect) mechanism supportive of a threshold will have important implications for risk assessment of silica NPs.
Materials and methods

Silica NPs and chemicals
Amorphous silica (Levasil® 200/40%), with a mean particle size of 15 nm according to supplier data, was obtained from HC Stark (Leverkusen, Germany). This material has no surface charge and is supplied as an aqueous alkaline (pH ~10) colloidal dispersion of amorphous silica (SiO 2 ) containing 40% solids and 1.75 × 10 17 particles/ml. These silica particles were characterised in an earlier study (4) by transmission electron microscopy, which suggested that the average size of the particles was consistent with the size given by the supplier, although there was clearly a 2-to 3-fold range in the particle sizes. However, measurement of the particle sizes by dynamic light scattering showed that the average particle size was ~2-fold larger than the size given by the supplier and was not affected by neutralising the pH of the dispersion, which was necessary for i.v. administration.
Ethyl methanesulfonate (EMS), agarose Type I, KBrO 3 and other chemicals used for the comet assay solutions were purchased from Sigma-Aldrich (St Louis, MO, USA). SeaPlaque GTG low-meltingpoint agarose (LMA; Lonza) was obtained from VWR Scientific Products (Radnor, PA, USA), and SYBR Gold nucleic acid gel stain was purchased from Life Technologies (Grand Island, NY, USA). Human 8-oxo-guanine DNA glycosylase (hOGG1) protein and 100× FLARE buffer BSA enzyme-stabilising additive were obtained from Trevigen Inc. (Gaithersburg, MD, USA).
Animals
All experimental protocols were reviewed and approved by P&G's IACUC (Institutional Animal Care and Use Committee) and by an internal bioethics review group that evaluated the need for experimentation with animals. Animal care was conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals (8th edn, 2011).
The animals were allowed to acclimate for 1 week after arrival and were handled daily to minimise stress prior to their use in the studies. Adult male Wistar rats (150-200 g) were purchased from Charles River Laboratories (Portage, MI, USA). Rats were individually housed in constant temperature (22 ± 1°C) and humidity (50 ± 10%) with a 12:12 h light/dark cycle and had free access to food and water.
Intravenous injection of silica NPs
The Levasil® 200 particles were freshly prepared prior to administration by making an initial 1:5 dilution in Dulbecco's phosphatebuffered saline (DPBS) and then were neutralised to pH 7.5 for injection with the addition of 0.1 N HCl due to the high alkalinity (pH 10) of the dispersion. Further dilutions with DPBS to the final concentration (5-50 mg/ml) were made as needed. The particles were administered by an i.v. (tail vein) injection at 1, 2, 4, 8 or 24 h before sacrifice (n = 5-8 animals per group). For the corresponding controls, two animals were used for the 1-and 2-h time points and three to four rats were used for the 4-, 8-and 24-h time points and the positive controls. Rats were placed into Broome restraints (Plas-Labs, Lansing, MI, USA), and their tails were gently heated with warm water. The silica particles were injected in a total volume of 0.2-0.25 ml (1 ml/kg) using a 25-g winged infusion set followed by flushing the cannula with 0.4 ml of sterile saline. The injections were spaced at 15-min intervals between the dosed animals to allow adequate time for tissue and blood collection and preparation of slides for the comet assay.
Administration of positive control compounds
EMS was diluted 1:40 by drop-wise addition to saline while vortexing just prior to dosing, yielding a 30 mg/ml solution. Rats were given a single dose of 300 mg/kg EMS by oral gavage 4 h prior to sacrifice in a volume of 10 ml/kg. KBrO 3 was dissolved in saline at 40 mg/ml just prior to dosing, and rats were administered a single dose of 400 mg/kg by oral gavage 4 h before sacrifice in a volume of 10 ml/kg.
Tissue and blood collection
Rats were euthanised with CO 2 , and an incision was made in the abdomen to expose the abdominal organs. In order to collect blood, 8-10 ml of blood was immediately drawn from the abdominal vena cava into a syringe containing Na 2 EDTA.2H 2 O (final concentration, 1.6 mg/ml blood) and placed on ice. An aliquot of the blood was then removed for the comet assay and the remaining blood was centrifuged at 2000 g for 10 min at 4°C, the plasma removed and stored frozen at −80°C. In order to minimise white blood cell contamination, the liver was rinsed before collection with 10 ml of ice-cold saline via the hepatic portal vein. For the comet assay, ~1 g of the left lateral lobe of the liver was removed and rinsed briefly in icecold tissue mincing buffer [Hank's balanced salt solution, containing 20 mM EDTA and 10% dimethyl sulfoxide, pH 7.5]. In the vehicleand KBrO 3 -treated rats, the left kidney was also removed and rinsed briefly in ice-cold tissue mincing buffer. Several lobes of the liver and the right kidney were cut into smaller pieces, snap frozen with liquid nitrogen and stored at −80°C. One lobe of the liver was fixed in 10% neutral-buffered formalin and paraffin-embedded for histopathology.
Standard alkaline and hOGG1-modified alkaline comet assay
The comet assay was carried out according to Tice et al. (9) and Singh et al. (10) using alkaline conditions in all samples. Immediately after collection, cell suspensions for the comet assay were prepared by mincing the tissues on ice into 1-to 2-mm pieces with a pair of fine dissecting scissors in a petri dish containing 4-ml ice-cold tissue mincing buffer and filtering the suspensions by gravity through 70-µm cell strainers (BD Falcon, Bedford, MA, USA) into collection tubes. The liver and kidney cell suspensions were kept on ice before being diluted 1:10 with 0.5% LMA solution in DPBS (maintained at 37°C), and for blood, a 1:30 dilution of the whole blood sample with 0.5% LMA was used. Comet slides from each tissue were prepared in triplicate by spreading 75 µl of the cell suspension onto separate microscope slides that were previously coated with a 1% agarose solution in DPBS and allowed to dry. The cell suspensions were covered by 1-mm glass coverslips, and the LMA was allowed to solidify at 4°C for 3-4 min before the coverslips were removed. The slides were then placed in staining trays in Wheaton staining dishes containing 200-ml cold lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 1% Triton X-100, pH 10), and the cells were lysed overnight at 4°C.
After cell lysis was complete, four slides from the 4-h kidney samples (vehicle and KBrO 3 -treated rats only), and the 2-, 4-, 8-and 24-h liver samples (all rats) were prepared for measurement of oxidative DNA damage by incubation with hOGG1 prior to the alkaline electrophoresis step. These slides (four per tissue) were transferred from the lysis buffer into another staining dish containing 200 ml 1× FLARE buffer (10 mM HEPES-KOH, 100 mM KCl, 10 mM EDTA, pH 7.4). The slides were washed with FLARE buffer (3 × 10 min washes at room temperature), and the backs and sides of slides were blotted with a paper towel to remove excess wash buffer. 150 µl 1× FLARE reaction buffer (1× FLARE buffer containing 1× BSA enzyme-stabilising additive) or hOGG1 enzyme solution (0.5 U hOGG1 equivalent/ slide in 1× FLARE reaction buffer) was added to duplicate slides from each tissue. A parafilm coverslip was carefully placed on the top of the slides, and the slides were placed inside a preheated humidity chamber box (Shandon Scientific) containing moistened paper towels inside a humidified CO 2 incubator at 37°C for 30 min. The slides were then dipped in a beaker containing 1× FLARE buffer to remove the coverslip and washed (1 × 10 min) in a staining dish containing 200 ml 1× FLARE buffer before undergoing electrophoresis.
All slides from the hOGG1-modified alkaline comet assay and the standard comet assay were prepared for electrophoresis by transferring the slides to fresh staining dishes containing cold alkaline electrophoresis solution (0.3 N NaOH, 1 mM EDTA, pH 13.2) and incubated for 20 min at 4°C for the DNA unwinding step. Electrophoresis was carried out in the alkaline electrophoresis solution using a MAXI electrophoresis chamber (#N610.1, Carl Roth, Karlsruhe, Germany) and a PowerPac HC power supply (Bio-Rad Laboratories, Hercules, CA, USA) set to a constant voltage (39 V). The current was adjusted to 450 ± 50 mA, and the electrophoresis was run for 30 min at 4°C. The slides were then transferred to neutralisation buffer (0.4 M Tris, pH 7.5) for 15 min at 4°C followed by washing in 96% ethanol for 5 min. The slides were air-dried, stored at room temperature and protected from light and dust until scoring.
For evaluation of DNA damage, the slides were randomised and coded so that the treatment group was blinded to the scorer. SYBR Gold stain was diluted 1:10 000 in staining buffer (50 mM Tris, pH 7.5), and slides were incubated in the dark at room temperature for 15 min. The slides were covered with glass coverslips, and the backs were dried off and kept in the dark. DNA damage was measured using a Leica DM2000 fluorescence microscope (Leica Microsystems, Buffalo Grove, IL, USA) using a ×20 objective. The scoring and evaluation of comet images was carried out using an automated image analysis system (Comet Assay IV™, version 4.11, Perceptive Instruments, Suffolk, UK) with a high-definition CCD video camera (Marlin F-046B, Allied Technologies, Stadtroda, Germany) to measure the % tail DNA (0-100%). A total of 150 nuclei per tissue for each animal (50 nuclei/slide) were scored.
Histopathology and histology in liver
Animals were assessed by gross pathology during necropsy, and the liver weights were recorded. Tissue sections (3-5 µm) were prepared from paraffin-embedded liver tissues, stained with hematoxylin and eosin and examined by a board-certified veterinary pathologist (Vet Path Services Inc., Mason, OH, USA).
RNA isolation and gene expression analysis
Gene expression profiling was performed on liver tissue at each time point (1, 2, 4, 8 and 24 h) following injection of the silica NPs and at 4 h after the administration of EMS or KBrO 3 . Total RNA was isolated from frozen liver tissues by homogenisation in RNAzol®RT (1 ml/100 mg tissue; Molecular Research Center Inc., Cincinnati, OH, USA) using the TissueLyser LT (Qiagen, Valencia, CA, USA), and RNA was extracted according to the manufacturer's protocol. RNA was further purified using RNEasy spin columns (Valencia, CA, USA) and run on an Agilent Technologies (Santa Clara, CA, USA) RNA chip for concentration determination and integrity evaluation. Five hundred nanogram of RNA was converted to GeneChip targets using Affymetrix IVT Express kit and 6 µg of target was hybridised to Affymetrix GeneChip® HT RG-230 PM Array Plates (Affymetrix, Santa Clara, CA, USA). Array data were analysed using Partek Genomics Suite (version 6.6; Partek Incorporated, St Louis, MO, USA). The robust multi-array average algorithm was used for gene-level intensity analyses. Statistical analysis was performed on the normalised, log2-transformed data using the analysis of variance (ANOVA) with pairwise contrasts between the vehicle control and each treatment within each time point (one-way ANOVA). Pathways enriched among statistically significant (P < 0.0001, fold change > 1.1 or < 1.1), differentially expressed genes in the data were identified using MetaCore database (MetaCore™ version 6.27 build 68571, Thomson Reuters).
Statistical analyses
The comet assay data were analysed using a t-test or a one-way ANOVA in which the treatment groups were individually compared to the vehicle control group with Dunnett's multiple comparison test, and a P < 0.05 was considered a significant difference. All analyses were carried out using Prism version 6.07 (GraphPad Software Inc., LaJolla, CA, USA).
Results
DNA damage with alkaline and hOGG1-modified alkaline comet assays
Exposure of animals to a single i.v. injection of 15-nm silica NPs at 50 mg/kg resulted in an small increase in DNA damage in the liver (Figure 1 ) and in blood (data not shown) as determined in the standard alkaline comet assay, but was not significantly different than controls at 4, 8 or 24 h after administration. This dose of 15-nm silica NPs was previously shown by our lab to be the MTD (based on survival). A clear increase in DNA damage was observed in the liver in the positive control (EMS) group (Figure 1 ) at 4 h after dosing.
In the hOGG1-modified alkaline comet assay, injection of 15-nm silica NPs at 50 mg/kg resulted in a small, statistically significant increase in the OGG1-sensitive DNA damage in the liver at 4 h after administration, but not at 2 or 8 h (Figure 2 , 8-h data not shown). A clear increase in the OGG1-sensitive DNA damage was observed in the positive control groups in the liver in response to EMS and KBrO 3 and an even stronger increase in the kidney in response to KBrO 3 at 4 h after dosing (Figure 2 ).
Liver histopathology
The livers from rats injected intravenously with the silica NPs were evaluated by histopathology at 4 and 24 h after administration of the particles. Vehicle control animals had minimal mononuclear cell infiltration, primarily in portal regions at the 4-h time point, which is a common spontaneous background finding in Wistar rats. In rats treated with the 15-nm silica NPs at 50 mg/kg, five of eight animals had minimal sinusoidal neutrophilic infiltration and three of eight animals had minimal portal neutrophilic infiltration. Mononuclear cell infiltration was similar to controls. At the 24-h time point, there were no microscopic findings in the vehicle controls, while six of seven animals injected with 15-nm silica NPs at 50 mg/kg had mild mononuclear cell infiltration in portal areas and in small clusters within sinusoids. Minimal infiltration of neutrophils in sinusoids and portal areas occurred in all of the animals treated with 15-nm silica NPs at 50 mg/kg and a minimal increase in Kupffer cell mitotic figures occurred in six of seven animals at 24 h after particle administration. In contrast, there were no findings associated with the administration of 15-nm silica NPs at 5 mg/kg at 24 h, as the histopathology in the livers of the animals in this group was indistinguishable from those of the vehicle controls.
Liver gene expression
Analysis of the gene expression profile was performed in the liver at 1, 2, 4, 8 and 24 h following injection of 15-nm silica NPs at 50 mg/ kg. Process network rankings indicated that the predominant cellular processes activated involved inflammatory and immune responses (Figure 3) . Several of these processes, inflammation via IL-6 signalling and immune processes via Th17-derived cytokines, showed biphasic responses, peaking at 1 h and again at 4-8 h after exposure to the silica NPs. A variety of inflammatory and immune process networks showed strong responses through the 4-to 8-h period, which also included robust activation of cell cycle and apoptotic responses. Late immune responses involving phagocytosis showed peak activation levels at 24 h (Figure 3 ). Pathway mapping also showed the activation of responses to oxidative stress and hypoxia after exposure to the silica NPs (not shown).
Analysis of the gene expression relative to vehicle-injected animals using the Affymetrix GeneChip array data for several key genes involved in the activated cellular processes networks showed that increased Ho-1 expression (oxidative stress response, Figure 4a ) began by 1 h and peaked at 4 h after exposure. In contrast, upregulation of Ccl2 (inflammatory damage response, Figure 4b ), NfKB1 (p105/p50, immune response, Figure 4c ), Lcn2 (lipocalin 2, hypoxia and immune response, Figure 4d ), Hyou1 (hypoxia upregulated protein 1, hypoxia response, Figure 4e ) and p53 (DNA repair response, Figure 4f ) began at 2-4 h and peaked at 8 h following after exposure to the silica NPs.
Discussion
In a previous study, we have shown that silica NPs, if administered intravenously at their MTD, induced small increases in DNA damage as measured in the in vivo comet and micronucleus assays (4) . This follow-up study investigates the relationship between DNA damage and inflammation by measuring gene expression and DNA damage at 1, 2, 4, 8 and 24 h after a single i.v. injection, again reflecting a were administered once orally at 4 h prior to tissue collection. Statistically significant *P < 0.05; **P < 0.01; ***P < 0.001.
'worst-case' exposure scenario that is focusing on potential hazards by maximising exposure with no direct correlation to human exposure of such particles. The dose we selected for i.v. injection (50 mg/ kg bw 15-nm Levasil® 200 silica NPs) was chosen to mirror the previous assay conditions, which had resulted in small increases in DNA damage in liver and lung tissue, and in white blood cells, after three i.v. applications of the NPs 48, 24 and 4 h before sacrifice. The small increase in DNA damage measured using the alkaline comet assay (up to 1.7-fold, if compared to concurrent control animals) was reproduced in an independent second study (4), with the most pronounced effects showing for the liver. We utilised a single application protocol in the present study to gain MoA insights, and it may therefore not be surprising that the standard comet assay did not show statistically significant increases in DNA damage at any of the measured time points. There was, however, a trend towards increasing DNA damage over time, with the maximum increase (1.3-fold) showing for the 24-h treatment group (see Figure 1) . While falling within the variability of the assay, this result is consistent with the above-described effects observed using a triple application protocol. Seen in isolation, however, this small increase does not give a clear indication of DNA damage.
If maximal sensitivity for detection of oxidative DNA damage in the comet assay is desired, the use of DNA glycosylases has shown to be beneficial (7, 11, 12) . This concept has already been utilised to study NPs, e.g. Bourdon et al. (13) have shown that an FPG protocol increased the comet effects they had observed in the standard comet protocol. Sharma et al. (14) found a positive response when using the FPG protocol, but no data were generated in parallel with the standard comet assay. In the present study, the use of OGG1 DNA glycosylase boosted measurable DNA damage for animals treated with the high dose (50 mg/kg bw) of 15-nm silica NPs. No increase was seen in the 2-h treatment group, while the 4-h group showed a clear (>2-fold) increase vs its buffer control, which was also statistically significant (P < 0.01). The differences in the response likely reflect the kinetics of the underlying toxicological mechanism discussed hereafter, showing that inflammatory responses increase steeply between 2 and 4 h (see Figure 3 and 4b). Inflammatory liver injury by silica NPs was also reported by Nishimori et al. (15, 16) after injecting silica particles of 70-nm nominal size into mice via the tail vein. The positive control EMS, a direct acting genotoxin that can also induce oxidative stress (17) , showed a strong DNA damage response without addition of OGG1 but, as expected, the glycosylase did further boost the DNA damage level (Figure 2) . KBrO 3 , a rodent carcinogen known to act through an oxidative stress MoA and was shown to produce DNA damage in the comet assay in the kidneys of treated rats (18) (19) (20) , did not lead to DNA damage in the liver or kidney of rats when using the standard comet assay protocol but caused a clear effect with the OGG1 protocol in the liver and an even more pronounced increase in the target organ of its carcinogenic activity, the kidney (Figure 2 ).
For our previous study, insight into liver toxicity came from histopathological analysis showing, e.g., clear indication of mononuclear cell infiltration and neutrophilic infiltration, hepatocellular necrosis and increases in Kupffer cell mitotic figures (4) . In the present study, for the animals treated with 50 mg/kg bw using single treatments, minimal mononuclear cell infiltration began at the 4-h time point, while at the 24-h time point, this effect was more pronounced and an increase in Kupffer cell mitotic figures, an indication of increased cellular turnover, also became apparent. These effects were much less pronounced compared to those observed in our previous study, confirming that the single treatment schedule led to less liver toxicity. This decrease in toxicity matches the above-described reduction in DNA damage observed after single vs triplicate exposure. The absence of histopathological findings for the low dose of 5 mg/kg bw across all time points is consistent with a thresholded MoA, and it may therefore not be surprising that the gene array data also did not show any significant modulation for this group (data not shown).
When liver tissue was analysed for changes of transcriptional expression after exposure to 50 mg/kg bw 15-nm silica NPs, a clear time-dependent pattern evolved. Looking at the number of genes affected (Figure 3) , at 1 and 2 h, only a few genes were involved, and the process network rankings (Figure 3) indicate that inflammation signalling via IL-6 and immune response via Th-17 cytokines dominate the immediate response at 1 h. Interestingly, these showed biphasic responses, peaking at 1 h and again at 4-8 h after exposure to the silica NPs, which may indicate an initial immune reaction to the particulate material, while the second peak likely is a consequence of the observed inflammatory response triggered by tissue damage. Four and eight hours after treatment, the maximal response for NF-kB-mediated apoptosis was observed (Figure 3, no. 10, red bar) , indicating the presence of tissue damage that will trigger neutrophil infiltration as observed by histopathology. Furthermore, a strong activation of responses to hypoxia after exposure to the silica NPs also starts showing at 4 h after treatment, as indicated by the strong induction of key genes, Lcn2 (lipocalin 2, Figure 4d ) and Hyou1 (hypoxia upregulated protein 1, Figure 4e) . These peak at 8 h but are still upregulated after 24 h, suggesting a physical 'clogging' of liver vessels by nanomaterials that have agglomerated after injection into the animals via tail vein. The occurrence of 'clogging' of veins is also supported by mononuclear cell infiltration in small clusters within sinusoids as observed via histopathological examination.
The activation of NF-kB (Figure 4c ) is an important trigger of the immune complement system as described above. This is confirmed by the strong dominance of the 'Immune response_phagocytosis' and 'phagosome in antigen presentation' process networks demonstrated at 24 h ( Figure 3 , top 2, brown bar, and top 6, brown bar). The complement system plays a key role in removing damaged cells from an organism, which is done via promotion of inflammation by attracting neutrophils, but also by promoting phagocytosis via macrophages (21) . The process network analysis shows that by 24 h the immune response had shifted towards phagocytosis with less neutrophil involvement and therefore less ROS generation involved, which is in line with the return of Ho-1 and NfKB1 to (or close to) control levels.
Taken together, we showed that the treatment of rats with a single injection of 50 mg/kg bw of 15-nm silica NPs leads to a slight and statistically insignificant increase in DNA damage as measured by the standard comet assay. With the addition of hOGG1 glycosylase, a statistically significant increase in DNA damage was observed at 4 h after treatment, which is consistent with a MoA involving ROS. Histopathology showed liver tissue damage and involvement of neutrophils, and the results of genomic analysis are also supportive of a tissue damage-mediated inflammatory response involving the complement system for removing/phagocytising damaged cells. No changes vs control were observed for histopathology or gene array for the low-dose group (5 mg/kg bw) of silica NPs.
The results of this study confirm our hypothesis that the weak DNA damage response we observed in this study and also previously (4) occurs secondary to inflammation/immune response, indicating that a threshold can be applied in the risk assessment of the silica NPs investigated in this study. Chronic inflammation has been postulated as the MoA for induction of lung cancer by crystalline silica (quartz), an IARC Group 1 carcinogen, despite its capability to induce genotoxic effects as demonstrated in many assays (22, 23) . It has been suggested that the observed genotoxic effects of crystalline silica occurred secondary to inflammatory cell-derived oxidants and a thresholded effect was therefore assumed (23), indicating that exposures avoiding local inflammation will also avoid downstream effects. Although the quartz example does represent a relevant human exposure scenario for certain professions (mining, inhalation), it seems important to emphasise that the exposure route selected here, i.v. injection, was chosen to maximise exposure to enable mechanistic insights only and has no correlation to realistic human exposures with silica NPs.
Funding
This study was funded by the Procter & Gamble Company.
